Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025711 | 12602571 | 1 | I | 201508 | 20160718 | 20160728 | 20160728 | EXP | US-NOVOPROD-502477 | NOVO NORDISK | 87.00 | YR | E | F | Y | 69.84000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025711 | 12602571 | 1 | PS | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | U | U | UNKNOWN | 20986 | SOLUTION FOR INJECTION | |||||||
| 126025711 | 12602571 | 2 | SS | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | U | U | UNKNOWN | 0 | ||||||||
| 126025711 | 12602571 | 3 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 15 MG, QD | AD6457F | 0 | 15 | MG | QD | ||||||
| 126025711 | 12602571 | 4 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 5 | C | ATENOLOL. | ATENOLOL | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 6 | C | BALSALAZIDE | BALSALAZIDE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 7 | C | CALCIUM | CALCIUM | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 8 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 9 | C | FISH OIL | FISH OIL | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 10 | C | LASIX | FUROSEMIDE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 11 | C | WARFARIN | WARFARIN | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 12 | C | CEFUROXIME. | CEFUROXIME | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 13 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 14 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 15 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 16 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 17 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 18 | C | ASACOL | MESALAMINE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 19 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 20 | C | GAS-X | DIMETHICONE | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 21 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | UNKNOWN | 0 | ||||||||||
| 126025711 | 12602571 | 22 | C | MULTIVITAMIN /00097801/ | VITAMINS | 1 | UNK | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126025711 | 12602571 | 1 | Diabetes mellitus |
| 126025711 | 12602571 | 2 | Diabetes mellitus |
| 126025711 | 12602571 | 3 | Myelofibrosis |
| 126025711 | 12602571 | 4 | Product used for unknown indication |
| 126025711 | 12602571 | 5 | Product used for unknown indication |
| 126025711 | 12602571 | 6 | Product used for unknown indication |
| 126025711 | 12602571 | 7 | Product used for unknown indication |
| 126025711 | 12602571 | 8 | Product used for unknown indication |
| 126025711 | 12602571 | 9 | Product used for unknown indication |
| 126025711 | 12602571 | 10 | Product used for unknown indication |
| 126025711 | 12602571 | 11 | Product used for unknown indication |
| 126025711 | 12602571 | 12 | Product used for unknown indication |
| 126025711 | 12602571 | 13 | Product used for unknown indication |
| 126025711 | 12602571 | 14 | Product used for unknown indication |
| 126025711 | 12602571 | 15 | Product used for unknown indication |
| 126025711 | 12602571 | 16 | Product used for unknown indication |
| 126025711 | 12602571 | 17 | Product used for unknown indication |
| 126025711 | 12602571 | 18 | Product used for unknown indication |
| 126025711 | 12602571 | 19 | Product used for unknown indication |
| 126025711 | 12602571 | 20 | Product used for unknown indication |
| 126025711 | 12602571 | 21 | Product used for unknown indication |
| 126025711 | 12602571 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126025711 | 12602571 | OT |
| 126025711 | 12602571 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126025711 | 12602571 | Anaemia | |
| 126025711 | 12602571 | Incorrect dose administered | |
| 126025711 | 12602571 | Increased tendency to bruise | |
| 126025711 | 12602571 | Pneumonia | |
| 126025711 | 12602571 | Pulmonary thrombosis | |
| 126025711 | 12602571 | Shock hypoglycaemic | |
| 126025711 | 12602571 | Splenomegaly | |
| 126025711 | 12602571 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126025711 | 12602571 | 3 | 20120723 | 0 |